Literature DB >> 21568148

Epidemiologic profile and clinical characteristics of ulcerative colitis in northwest of Iran: a 10-year review.

Abbas Yazdanbod1, Esmaeil Farzaneh, Farhad Pourfarzi, Ahad Azami, Babak Mostafazadeh, Vahid Adiban, Mohammad Reza Rasouli.   

Abstract

BACKGROUND AND AIM: There are few reports from Iran about the epidemiology and clinical features of inflammatory bowel disease (IBD). In this study, we aimed to determine the epidemiologic profile and clinical features of ulcerative colitis (UC) in Northwest of Iran.
METHODS: This retrospective study covered the time period from 1998 to 2008 and included all patients of a private gasteroenterology clinic in the northwest of Iran, who had diagnosis of UC at the time of presentation or those whose diagnosis had been made later. In addition to description of epidemiology and clinical feature of disease, an attempt was made to identify factors associated with severity of disease.
RESULTS: A total of 105 patients including 61 females (58.1%) were evaluated. Mean age of the patients was 33.5 +/- 13.1 years. The median time interval from initiation of symptoms to diagnosis was 9 months. The commonest presentation was proctosigmoiditis. (48.6%). Among extra-intestinal manifestations, sclerosing cholangitis had the highest frequency and was found in 2 (1.9%) patients. Among all evaluated variables, only family income (the higher the income the more severe the disease) and cigarette smoking (inverse association) were find to have significant association with severity of disease.
CONCLUSION: A case profile of patients with ulcerative colitis from Northwest Iran suggests that the disease is seen most commonly in the third decade of life with a female preponderance. Family income and smoking influenced the course of ulcerative colitis in Iranian patients.

Entities:  

Mesh:

Year:  2010        PMID: 21568148

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  6 in total

1.  Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach.

Authors:  Silvio Danese; Rupa Banerjee; Jr Fraser Cummings; Iris Dotan; Paulo G Kotze; Rupert Wing Loong Leong; Kristine Paridaens; Laurent Peyrin-Biroulet; Glyn Scott; Gert Van Assche; Jan Wehkamp; Jesús K Yamamoto-Furusho
Journal:  Intest Res       Date:  2018-10-16

Review 2.  Epidemiological, Demographic, and Colonic Extension ofUlcerative Colitis in Iran: A Systematic Review.

Authors:  Ali Akbar Shayesteh; Mehdi Saberifirozi; Shifteh Abedian; Vahid Sebghatolahi
Journal:  Middle East J Dig Dis       Date:  2013-01

Review 3.  Inflammatory bowel disease.

Authors:  Siavosh Nasseri-Moghaddam
Journal:  Middle East J Dig Dis       Date:  2012-04

4.  Epidemiological and clinical characteristics of inflammatory bowel disease in patients from northwestern iran.

Authors:  Kourosh Masnadi Shirazi; Mohammad Hossein Somi; Yoosef Bafandeh; Firooz Saremi; Nooshin Mylanchy; Parisa Rezaeifar; Nasim Abedi Manesh; Seyed Kazem Mirinezhad
Journal:  Middle East J Dig Dis       Date:  2013-04

5.  Pulmonary function and methacholine challenge tests in patients with ulcerative colitis.

Authors:  Maryam Taherzadeh; Homayoon Vahedi; Keivan Gohari Moghadam; Javad Shakeri; Mehedi Chaharmahali; Omalbanin Paknejad
Journal:  Tanaffos       Date:  2012

6.  Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study.

Authors:  Koroush Ghanadi; Javad Valizadeh; Afshin Hasanvand
Journal:  Springerplus       Date:  2016-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.